- Home
- KNSA vs COCO Comparison
KNSA vs COCO Comparison
Compare KNSA & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- COCO
- Stock Information
- Founded
- KNSA 2015
- COCO 2004
- Country
- KNSA United Kingdom
- COCO United States
- Employees
- KNSA N/A
- COCO N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- COCO Beverages (Production/Distribution)
- Sector
- KNSA Health Care
- COCO Consumer Staples
- Exchange
- KNSA Nasdaq
- COCO Nasdaq
- Market Cap
- KNSA 1.6B
- COCO N/A
- IPO Year
- KNSA 2018
- COCO 2021
- Fundamental
- Price
- KNSA $23.09
- COCO $29.85
- Analyst Decision
- KNSA Strong Buy
- COCO Buy
- Analyst Count
- KNSA 6
- COCO 6
- Target Price
- KNSA $37.17
- COCO $35.17
- AVG Volume (30 Days)
- KNSA 684.1K
- COCO 701.0K
- Earning Date
- KNSA 04-22-2025
- COCO 04-30-2025
- Dividend Yield
- KNSA N/A
- COCO N/A
- EPS Growth
- KNSA N/A
- COCO 18.99
- EPS
- KNSA N/A
- COCO 0.94
- Revenue
- KNSA $423,239,000.00
- COCO $516,013,000.00
- Revenue This Year
- KNSA $37.21
- COCO $12.42
- Revenue Next Year
- KNSA $1.38
- COCO $10.73
- P/E Ratio
- KNSA N/A
- COCO $31.76
- Revenue Growth
- KNSA 56.60
- COCO 4.54
- 52 Week Low
- KNSA $16.56
- COCO $23.00
- 52 Week High
- KNSA $28.15
- COCO $40.32
- Technical
- Relative Strength Index (RSI)
- KNSA 60.12
- COCO 29.89
- Support Level
- KNSA $22.62
- COCO $33.99
- Resistance Level
- KNSA $23.42
- COCO $36.50
- Average True Range (ATR)
- KNSA 0.75
- COCO 1.32
- MACD
- KNSA -0.01
- COCO -0.44
- Stochastic Oscillator
- KNSA 68.88
- COCO 2.64
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.